Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Dose constraints to prevent radiation-induced brachial plexopathy in patients treated for lung cancer.
Amini A, Yang J, Williamson R, McBurney ML, Erasmus J Jr, Allen PK, Karhade M, Komaki R, Liao Z, Gomez D, Cox J, Dong L, Welsh J.
Int J Radiat Oncol Biol Phys. 2012 Mar 1;82(3):e391-8.
Related citations
Treatment for pathologic stage I lung cancer--are models reliable?
Puri V, Crabtree TD, Meyers BF.
Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):522; author reply 523. No abstract available.
Stereotactic radiotherapy of primary lung cancer and other targets: results of consultant meeting of the International Atomic Energy Agency (Int J Radiat Oncol Biol Phys 2011;79:660-669).
Atalar B, Caglar H, Ozyar E.
Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):521; author reply 521. No abstract available.
Individualized Dose Prescription for Hypofractionation in Advanced Non-small-cell Lung Cancer Radiotherapy: An in silico Trial.
Hoffmann AL, Troost EG, Huizenga H, Kaanders JH, Bussink J.
Int J Radiat Oncol Biol Phys. 2012 Jan 13. [Epub ahead of print]
Respiration-correlated image guidance is the most important radiotherapy motion management strategy for most lung cancer patients.
Korreman S, Persson G, Nygaard D, Brink C, Juhler-Nøttrup T.
Functional image-guided radiotherapy planning in respiratory-gated intensity-modulated radiotherapy for lung cancer patients with chronic obstructive pulmonary disease.
Kimura T, Nishibuchi I, Murakami Y, Kenjo M, Kaneyasu Y, Nagata Y.
Int J Radiat Oncol Biol Phys. 2012 Mar 15;82(4):e663-70. Epub 2012 Jan 13.
Proton stereotactic body radiation therapy for clinically challenging cases of centrally and superiorly located stage I non-small-cell lung cancer: in regards to Register et al. Int J Radiat Oncol Biol Phys 2011;80:1015-1022.
Bongers EM, Dahele MR, Slotman BJ, Senan S, Bot JC.
Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):492; author reply 492. No abstract available.
Local failure in resected n1 lung cancer: implications for adjuvant therapy.
Higgins KA, Chino JP, Berry M, Ready N, Boyd J, Yoo DS, Kelsey CR.
Int J Radiat Oncol Biol Phys. 2012 Jun 1;83(2):727-33. Epub 2011 Dec 28.
Tumor, lymph node, and lymph node-to-tumor displacements over a radiotherapy series: analysis of interfraction and intrafraction variations using active breathing control (ABC) in lung cancer.
Weiss E, Robertson SP, Mukhopadhyay N, Hugo GD.
Int J Radiat Oncol Biol Phys. 2012 Mar 15;82(4):e639-45. Epub 2011 Dec 22.
Changes in global function and regional ventilation and perfusion on SPECT during the course of radiotherapy in patients with non-small-cell lung cancer.
Yuan ST, Frey KA, Gross MD, Hayman JA, Arenberg D, Cai XW, Ramnath N, Hassan K, Moran J, Eisbruch A, Ten Haken RK, Kong FM.
Int J Radiat Oncol Biol Phys. 2012 Mar 15;82(4):e631-8. Epub 2011 Dec 22.
Role of insulin-like growth factor-1 signaling pathway in cisplatin-resistant lung cancer cells.
Sun Y, Zheng S, Torossian A, Speirs CK, Schleicher S, Giacalone NJ, Carbone DP, Zhao Z, Lu B.
Int J Radiat Oncol Biol Phys. 2012 Mar 1;82(3):e563-72. Epub 2011 Dec 22.
Determination of internal target volume from a single positron emission tomography/computed tomography scan in lung cancer.
Chang G, Chang T, Pan T, Clark JW, Mawlawi OR.
Int J Radiat Oncol Biol Phys. 2012 May 1;83(1):459-66. Epub 2011 Dec 22.
Impact of Prophylactic Cranial Irradiation Timing on Brain Relapse Rates in Patients with Stage IIIB Non-small-cell Lung Carcinoma Treated with Two Different Chemoradiotherapy Regimens.
Topkan E, Parlak C, Kotek A, Yuksel O, Cengiz M, Ozsahin M, Pehlivan B.
Int J Radiat Oncol Biol Phys. 2011 Dec 13. [Epub ahead of print]
In regard to Gopal et al. ACR appropriateness criteria on induction and adjuvant therapy for stage N2 non-small-cell lung cancer: expert panel on radiation oncology-lung (Int J Radiat Oncol Biol Phys 2010;78:969-974).
Hastings J, Iganej S.
Int J Radiat Oncol Biol Phys. 2011 Dec 1;81(5):1592-3. No abstract available.
Outcomes of stereotactic ablative radiotherapy in patients with potentially operable stage I non-small cell lung cancer.
Lagerwaard FJ, Verstegen NE, Haasbeek CJ, Slotman BJ, Paul MA, Smit EF, Senan S.
Int J Radiat Oncol Biol Phys. 2012 May 1;83(1):348-53. Epub 2011 Nov 19.
The impact of extent and location of mediastinal lymph node involvement on survival in Stage III non-small cell lung cancer patients treated with definitive radiotherapy.
Fernandes AT, Mitra N, Xanthopoulos E, Evans T, Stevenson J, Langer C, Kucharczuk JC, Lin L, Rengan R.
Int J Radiat Oncol Biol Phys. 2012 May 1;83(1):340-7. Epub 2011 Nov 19.
Effect of Recombinant Human Endostatin on Radiosensitivity in Patients with Non-Small-Cell Lung Cancer.
Jiang XD, Dai P, Wu J, Song DA, Yu JM.
Int J Radiat Oncol Biol Phys. 2011 Nov 16. [Epub ahead of print]
Long-term clinical outcome of intensity-modulated radiotherapy for inoperable non-small cell lung cancer: the MD Anderson experience.
Jiang ZQ, Yang K, Komaki R, Wei X, Tucker SL, Zhuang Y, Martel MK, Vedam S, Balter P, Zhu G, Gomez D, Lu C, Mohan R, Cox JD, Liao Z.
Int J Radiat Oncol Biol Phys. 2012 May 1;83(1):332-9. Epub 2011 Nov 11.
A Phase I study of chemoradiotherapy with use of involved-field conformal radiotherapy and accelerated hyperfractionation for Stage III non-small cell lung cancer: WJTOG 3305.
Tada T, Chiba Y, Tsujino K, Fukuda H, Nishimura Y, Kokubo M, Negoro S, Kudoh S, Fukuoka M, Nakagawa K, Nakanishi Y.
Int J Radiat Oncol Biol Phys. 2012 May 1;83(1):327-31. Epub 2011 Nov 11.
Re: Devic et al. (Int J Radiat Oncol Biol Phys 2010;78:1555-1562).
Evans SM, Koch CJ.
Int J Radiat Oncol Biol Phys. 2011 Nov 1;81(3):902; author reply 902-3. No abstract available.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on